Double Medical Technology, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000032W7
CNY
48.30
-0.66 (-1.35%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
650.88
542.64
598.92
557.95
530.08
422.56
402.75
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
650.88
542.64
598.92
557.95
530.08
422.56
402.75
Raw Material Cost
192.97
176.23
195.38
172.75
192.27
144.97
133.12
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.79
2.12
0.97
0.99
1.82
2.70
3.47
Selling and Distribution Expenses
204.42
182.54
214.21
191.77
183.78
159.92
194.33
Other Expenses
7.80
7.07
8.80
7.46
7.08
5.40
8.66
Total Expenditure (Excl Depreciation)
477.19
431.59
498.56
440.10
448.68
361.62
417.48
Operating Profit (PBDIT) excl Other Income
173.70000000000002
111.1
100.39999999999999
117.89999999999999
81.4
60.9
-14.7
Other Income
18.80
26.32
54.68
11.77
24.04
24.16
27.66
Operating Profit (PBDIT)
227.44
188.83
196.67
176.55
146.56
134.19
18.99
Interest
1.79
2.12
0.97
0.99
1.82
2.70
3.47
Exceptional Items
5.82
2.30
2.07
6.08
-3.61
-1.43
5.49
Gross Profit (PBDT)
457.91
366.42
403.54
385.20
337.81
277.59
269.63
Depreciation
60.87
60.87
57.02
57.02
54.06
54.06
51.56
Profit Before Tax
170.61
128.13
140.75
124.61
87.06
76.00
-30.55
Tax
23.91
15.59
18.61
12.27
3.45
8.79
0.59
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
141.16
103.10
116.93
101.63
76.52
61.73
-38.74
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
141.16
103.10
116.93
101.63
76.52
61.73
-38.74
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
5.54
9.44
5.22
10.71
7.09
5.47
7.61
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
146.70
112.54
122.14
112.34
83.61
67.20
-31.13
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,143.12
3,193.86
3,078.99
3,163.19
3,090.76
3,118.32
3,058.49
Earnings per share (EPS)
0.35
0.25
0.28
0.25
0.18
0.15
-0.09
Diluted Earnings per share
0.35
0.25
0.28
0.25
0.18
0.15
-0.09
Operating Profit Margin (Excl OI)
22.7%
18.73%
14.19%
19.31%
12.91%
13.24%
-14.95%
Gross Profit Margin
35.56%
34.83%
33.02%
32.55%
26.62%
30.78%
5.22%
PAT Margin
21.69%
19.0%
19.52%
18.22%
14.43%
14.61%
-9.62%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 19.96% vs -9.40% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 30.40% vs -7.86% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 28.37% vs 14.44% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -14.29% vs 110.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Double Medical Technology, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
650.88
0
650.88
Other Operating Income
0.00
0.00
0.00
Total Operating income
650.88
0
650.88
Raw Material Cost
192.97
0
192.97
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.79
0
1.79
Selling and Distribution Expenses
204.42
0
204.42
Other Expenses
7.80
0.00
7.80
Total Expenditure (Excl Depreciation)
477.19
0
477.19
Operating Profit (PBDIT) excl Other Income
173.68
0.00
173.68
Other Income
18.80
0
18.80
Operating Profit (PBDIT)
227.44
0
227.44
Interest
1.79
0
1.79
Exceptional Items
5.82
0
5.82
Gross Profit (PBDT)
457.91
0
457.91
Depreciation
60.87
0
60.87
Profit Before Tax
170.61
0
170.61
Tax
23.91
0
23.91
Provisions and contingencies
0
0
0.00
Profit After Tax
141.16
0
141.16
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
141.16
0
141.16
Share in Profit of Associates
0
0
0.00
Minority Interest
5.54
0
5.54
Other related items
0.00
0.00
0.00
Consolidated Net Profit
146.70
0
146.70
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,143.12
0
3,143.12
Earnings per share (EPS)
0.35
0
0.35
Diluted Earnings per share
0.35
0
0.35
Operating Profit Margin (Excl OI)
22.70%
0%
0.00
22.70%
Gross Profit Margin
35.56%
0%
0.00
35.56%
PAT Margin
21.69%
0%
0.00
21.69%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 65.09 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 19.96% vs -9.40% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 22.79% vs 49.92% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 14.67 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 30.40% vs -7.86% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 75.48% vs 114.36% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.86 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 28.37% vs 14.44% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 70.29% vs 113.41% in Jun 2024

Quarterly - Interest
Interest 0.18 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -14.29% vs 110.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 0.00% vs 50.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.70%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024